JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms.
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Shuichi
S
Shirane
Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Marito
M
Araki
Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Soji
S
Morishita
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Yoko
Y
Edahiro
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.
Hiraku
H
Takei
Department of Biomedical Sciences, Seoul National University College of Medicine, Korea.
Yongjin
Y
Yoo
Department of Biomedical Sciences, Seoul National University College of Medicine, Korea.
Murim
M
Choi
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Yoshitaka
Y
Sunami
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Yumi
Y
Hironaka
Department of Hematology, Juntendo Urayasu Hospital, Chiba, Japan.
Masaaki
M
Noguchi
Department of Hematology, Juntendo Shizuoka Hospital, Japan.
Michiaki
M
Koike
Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, Japan.
Naohiro
N
Noda
Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Akimichi
A
Ohsaka
Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan komatsun@juntendo.ac.jp.
Norio
N
Komatsu
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D037282:Calreticulin / Q000235:genetics*; D015331:Cohort Studies; D004273:DNA, Neoplasm / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D009196:Myeloproliferative Disorders / Q000145:classification / Q000453:epidemiology / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011379:Prognosis; D053628:Receptors, Thrombopoietin / Q000235:genetics*; D055815:Young Adult
D037282:Calreticulin; D004273:DNA, Neoplasm; D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; C507924:JAK2 protein, human; D053614:Janus Kinase 2
CALR; JAK2; Japanese myeloproliferative neoplasm patients; MPL mutation